AC Immune SA (ACIU)
|Gross Profit (TTM)||-$56.40M|
|Year Range||$1.68 - $3.83|
Share Price Chart
The chart shows the growth of an initial investment of $10,000 in AC Immune SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
AC Immune SA had a return of 48.53% year-to-date (YTD) and 12.22% in the last 12 months.
|5 years (annualized)||-22.48%||11.63%|
|10 years (annualized)||N/A||9.72%|
Monthly Returns Heatmap
This table presents a comparison of risk-adjusted performance metrics for AC Immune SA (ACIU) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below displays the maximum drawdowns of the AC Immune SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AC Immune SA was 91.09%, occurring on Dec 22, 2022. The portfolio has not yet recovered.
|-91.09%||Sep 29, 2016||1570||Dec 22, 2022||—||—||—|
The current AC Immune SA volatility is 21.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.